Abstract
A group of 330 oncological patients were supported throughout a 7-year period with central venous catheters (Broviac/Hickman catheters) and underwent standard oncological chemotherapy, because of hematological malignancies or solid tumors (156 children), or a myeloablative conditioning regimen followed by bone marrow transplantation because of leukemia or lymphoma (174 patients: 110 adults, 64 children). Of these, 17 patients (8 after bone marrow transplantation) developed a catheter-related bacteremia and were treated by at least two antibiotics according to the sensitivity of the bacteria. In 1 patient the catheter (infected by Bacillus cereus) was removed on day 25 of antibiotic treatment because of persistent high fever and further positive blood cultures. After bone marrow transplantation, 2 other patients, with a Pseudomonas or a Staphylococcus infection respectively, did not respond to the combined antibiotic treatment and died 1 week and 7 weeks later, respectively, from transplant-related severe graft-versus-host disease. In the other 14 patients antibiotic treatment was successful and removal of the central-vein catheter could be avoided.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Darbyshire PJ, Weightman NC, Speller DCE (1985) Problems associated with indwelling central venous catheters. Arch Dis Child 60:129–134
Evans RC, Holmes CJ (1987) Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob Agents Chemother 31:889–894
Harms D, Gortitz I, Lambrecht W (1992) Infectious risks of Broviac catheters in children with neoplastic diseases: a matched pairs analysis. Pediatr Infec Dis J 11:1014–1018
Hickman RO, Buckner CD, Clift RA (1991) One has to question the indication of long-term venous access for TPN in patients with advances HIV disease. Aids Patients Care 7:120–124
King DR, Komer M, Hoffman J (1985) Brovia catheter sepsis: the natural history of an iatrogenic infection: J Pediatr Surg 20:728–733
Kurz RW, Hollenstein U, Krafft P (1991) Infektiöse Komplikationen durch zentralvenöse Kunststoffkatheter. Anaesthesist 40:262–270
Newman KA, Reed WP, Schimpff SC (1993) Hickman catheters in association with intensive cancer chemotherapy. Support Care Cancer 1:92–97
Raaf JH (1985) Results from the use of 826 vascular access devices in cancer patients. Cancer 55:1312–1321
Reed WP, Newman KA, Jongh C de (1983) Prolonged venous access for chemotherapy by means of the Hickman catheter. Cancer 53:185–192
Reilly JJ, Steed DL, Ritter PS (1984) Indwelling venous access catheters in patients with acute leucemia. Cancer 53:219–223
Sharpiro ED, Wald ER, Nelson KA (1982) Broviac catheter-related bacteremia in oncology patients. Am J Dis Child 136:679–681
Simon C, Simon M (1990) Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters. Scand J Infect Dis Suppl 72:14–19
Simon C, Lindner U, Hartlapp JH (1984) Therapie und Prophylaxe der Venenkatheter-Sepsis. Fortsch Antimikr Antineopl Chemother 3–6:1005–1014
Simon C, Stille W, Wilkinson P (1993) Antibiotic therapy, 2nd edn. Schattauer, Stuttgart, pp 333–334
Suttorp M, Wüstemann M, Rister M (1988) Der Einsatz des Broviac/Hickman-Katheters in der pädiatrischen Onkologie. Klin Pädiatr 200:49–56
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simon, C., Suttorp, M. Results of antibiotic treatment of Hickman-catheter-related infections in oncological patients. Support Care Cancer 2, 66–70 (1994). https://doi.org/10.1007/BF00355242
Issue Date:
DOI: https://doi.org/10.1007/BF00355242